Alumis Inc. (NASDAQ: ALMS), a promising name in the biotechnology sector, has been capturing investor attention with its dynamic approach to treating autoimmune disorders. As a clinical-stage biopharmaceutical company based..
ServiceTitan, Inc. (TTAN), a leader in the technology sector with its innovative software applications, is capturing significant attention from investors. With a market capitalization of $9.92 billion, the company stands..
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) is a promising player in the biotechnology sector, focusing on groundbreaking therapies for women’s cancers. As a clinical-stage biopharmaceutical company, Olema is at the forefront..
For investors with a keen eye on the biotechnology sector, Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) presents an intriguing opportunity marked by both promise and risk. With its focus on..
Neuronetics, Inc. (NASDAQ: STIM) is catching the attention of savvy investors thanks to its remarkable potential upside of over 322% and a robust revenue growth rate of 101.30%. As a..
Erasca, Inc. (NASDAQ: ERAS), a clinical-stage biotechnology company, is making waves in the healthcare sector with its focus on precision oncology. With a market cap of $1.03 billion, Erasca is..
Alpha Tau Medical Ltd. (NASDAQ: DRTS), an Israeli biotechnology company specializing in innovative cancer therapies, is capturing the attention of investors with a standout potential upside of 71.52%. Operating in..
Entrada Therapeutics, Inc. (NASDAQ: TRDA) is capturing the attention of investors with its promising potential upside of 47.06%, driven by innovative biotechnology developments and strong analyst confidence. As a clinical-stage..
Compass Therapeutics, Inc. (NASDAQ: CMPX) is capturing the attention of investors within the healthcare sector, specifically in the biotechnology industry. Headquartered in Boston, Massachusetts, this clinical-stage company is at the..
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is capturing the attention of investors with its promising pipeline in the biotechnology sector. As a company dedicated to developing innovative therapies for hematologic disorders..
Chevron Corporation (NYSE: CVX), a titan in the integrated oil and gas industry, stands as a stalwart in the energy sector with a substantial market capitalization of $301.26 billion. Based..
National Research Corporation (NRC), a key player in the Health Information Services industry, has carved a niche by providing analytics and insights to improve patient and employee experiences across healthcare..
Nano-X Imaging Ltd (NNOX), an innovative player in the healthcare sector, is making waves in the field of medical imaging with its cutting-edge digital X-ray technology. Headquartered in Petah Tikva,..
Abeona Therapeutics Inc. (NASDAQ: ABEO) is currently capturing significant attention from investors, partly due to its compelling upside potential of over 325%. As a trailblazing entity in the biotechnology sector,..
Alpha Teknova, Inc. (NASDAQ: TKNO) is carving a niche in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. As a U.S.-based company with a market capitalization..
Investors eyeing opportunities in the healthcare sector should take a closer look at Varex Imaging Corporation (NASDAQ: VREX), a key player in the medical devices industry with a notable potential..
Mereo BioPharma Group plc (NASDAQ: MREO), a distinguished name in the biotechnology sector, has emerged as a compelling player for investors keen on the healthcare space. With a current market..
Cytek Biosciences, Inc. (NASDAQ: CTKB), a prominent player in the medical devices sector, has been making waves with its innovative cell analysis solutions. With a market capitalization of approximately $615.03..
Investors seeking robust dividend income and potential price appreciation should take a closer look at Spok Holdings, Inc. (NYSE: SPOK). With a market capitalization of $276.63 million, Spok operates in..
Investors with an eye on the healthcare sector might find Outset Medical, Inc. (NASDAQ: OM) an intriguing prospect, particularly given its potential upside of 251.46%. This figure is driven by..
